Showing results (111-120 of 172) with videos related to
Sort By:
Pageof 18
Urologic Oncology|January 5, 2024
Clinical significance of prostate cancer identified by transperineal standard template biopsy in men with nonsuspicious multiparametric magnetic resonance imagingDouglas M Dahl, Shulin Wu, Sharron X Lin, et al.The Journal of Urology|February 22, 2021
Complications and Outcomes of Salvage Cystectomy after Trimodality TherapyAlberto Pieretti, Ross Krasnow, Michael Drumm, et al.The Journal of Urology|May 31, 2019
Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Biopsy Improves but Does Not Replace Standard Template Biopsy for the Detection of Prostate CancerNawar Hanna, Matthew F Wszolek, Amirkasra Mojtahed, et al.World Journal of Urology|May 14, 2015
Comparison of 30-day perioperative outcomes in adults undergoing open versus minimally invasive pyeloplasty for ureteropelvic junction obstruction: analysis of 593 patients in a prospective national databaseJulian Hanske, Alejandro Sanchez, Marianne Schmid, et al.Journal of Endourology|April 21, 2015
A Comparison of 30-Day Perioperative Outcomes in Open Versus Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Carcinoma: Analysis of 896 Patients from the American College of Surgeons-National Surgical Quality Improvement Program DatabaseJulian Hanske, Alejandro Sanchez, Marianne Schmid, et al.Urologic Oncology|January 8, 2016
Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohortAlejandro Sanchez, Dayron Rodríguez, Christopher B Allard, et al.The Journal of Urology|January 22, 2019
Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 YearsKeyan Salari, David Kuppermann, Mark A Preston, et al.Clinical Genitourinary Cancer|June 14, 2023
The Risk of Catastrophic Healthcare Expenditures Among Prostate and Bladder Cancer Survivors in the United StatesBenjamin V Stone, Muhieddine Labban, Dejan K Filipas, et al.NMR in Biomedicine|November 4, 2022
Designing a quality assurance process for quality control of nuclear magnetic resonance metabolomics studies of human bloodIsabella H Muti, Matteo Gonzalez Sanchez-Dahl, Anya B Zhong, et al.Urologic Oncology|October 11, 2025
PSA density as a dynamic prognostic marker of biopsy grade progression during active surveillanceAndrew Gusev, Florian Rumpf, Dimitar Zlatev, et al.Pageof 18